Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum

PLoS Neglected Tropical Diseases

Volumn 9, Issue 2, 2015, Pages

  Robertson, Alan P ^a   Puttachary, Sreekanth ^a   Buxton, Samuel K ^a   Martin, Richard J ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; CHOLINERGIC RECEPTOR; DERQUANTEL; LEVAMISOLE; METHYLLYCACONITINE; PARAHERQUAMIDE; RECEPTOR SUBTYPE; TRIBENDIMIDINE; UNCLASSIFIED DRUG; NICOTINIC AGENT; NICOTINIC RECEPTOR; PHENYLENEDIAMINE DERIVATIVE;

ADULT; ANIMAL TISSUE; ARTICLE; ASCARIASIS; ASCARIS SUUM; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; MEMBRANE POTENTIAL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OESOPHAGOSTOMIASIS; OESOPHAGOSTOMUM; OESOPHAGOSTOMUM DENTATUM; SWINE; ANIMAL; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; HUMAN;

ANIMALS; ANTHELMINTICS; ASCARIS SUUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEVAMISOLE; NICOTINIC AGONISTS; OESOPHAGOSTOMUM; PHENYLENEDIAMINES; RECEPTORS, NICOTINIC;

EID: 84924067815     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003495     Document Type: Article

References (21)

1. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, et al. (2003) Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 19: 547–551. 14642761
2. Keiser J, Utzinger J, (2008) Efficacy of current drugs against soil-transmitted helminth infections—Systematic review and meta-analysis. JAMA 299: 1937–1948. doi: 10.1001/jama.299.16.1937 18430913
3. Steinmann P, Zhou XN, Du ZW, Jiang JY, Xiao SH, et al. (2008) Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial. PLoS Negl Trop Dis 2: e322. doi: 10.1371/journal.pntd.0000322 18923706
4. Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W, (2005) Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94: 1–14. 15777691
5. Xu L-L, Jiang B, Duan J-J, Zhuang S-F, Liu Y-C, Zhu Z-Q, et al (2014). Efficacy and Safety of Praziquantel, Tribendimidine and Mebendazole in Patients with C-infection of Clonorchis sinensis and Other Helminthis. PloS Negl Trop Dis 8: e3046. doi: 10.1371/journal.pntd.0003046 25122121
6. Hu Y, Xiao SH, Aroian RV, (2009) The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist. PLoS Negl Trop Dis 3: e499. doi: 10.1371/journal.pntd.0000499 19668355
7. Boulin T, Gielen M, Richmond JE, Williams DC, Paoletti P, et al. (2008) Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor. Proc Natl Acad Sci U S A 105: 18590–18595. doi: 10.1073/pnas.0806933105 19020092
8. Buxton SK, Charvet CL, Neveu C, Cabaret J, Cortet J, et al. (2014) Investigation of acetylcholine receptor diversity in a nematode parasite leads to characterization of tribendimidine- and derquantel-sensitive nAChRs. PLoS Pathog 10: e1003870. doi: 10.1371/journal.ppat.1003870 24497826
9. Boulin T, Fauvin A, Charvet CL, Cortet J, Cabaret J, Bessereau J-L, et al (2011). Functional reconstitution of Haemonchus contortus acetylcholine receptors in Xenopus oocytes provides mechanistic insights into levamisole resistance. Brit J Pharmacol 164: 1421–1432. doi: 10.1111/j.1476-5381.2011.01420.x 21486278
10. Robertson AP, Clark CL, Burns TA, Thompson DP, Geary TG, et al. (2002) Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle. J Pharmacol Exp Ther 302: 853–860. 12183640
11. Martin RJ, Clark CL, Trailovic SM, Robertson AP, (2004). Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: Classification fo cholinergic anthelmintics in Ascaris. Int J Parasitol 34: 1083–1098 15313135
12. Qian H, Martin RJ, Robertson AP, (2006) Pharmacology of N-, L- and B- nAChR Subtypes of Nematode nAChR resolved at the single-channel level In Ascaris suum. FASEB J.20: 2606–2608. doi: 10.1096/fj.06-6264fje 17056760
13. Tritten L, Nwosu U, Vargas M, Keiser J, (2012) In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum. Acta Tropica 122: 101–107. doi: 10.1016/j.actatropica.2011.12.008 22210439
14. Martin RJ, Bai G, Clark CL, Robertson AP, (2003) Methyridine (2-[2-methoxyethyl]-pyridine]) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisole-resistance. Br J Pharmacol 140: 1068–1076. 14581174
15. Robertson AP, Bjorn HE, Martin RJ, (1999) Resistance to levamisole resolved at the single-channel level. FASEB J 13: 749–760. 10094935
16. Williamson SM, Robertson AP, Brown L, Williams T, Woods DJ, et al. (2009) The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog 5: e1000517. doi: 10.1371/journal.ppat.1000517 19609360
17. Guo R, Yuan G, Wang B, Wei C, Zhang R, (2009) Disposition and metabolism of tribendimidine in Chinese human. J Pharmacol Sci 109: 244P–244P.
18. Yuan G, Xu J, Qu T, Wang B, Zhang R, et al. (2010) Metabolism and disposition of tribendimidine and its metabolites in healthy Chinese volunteers. Drugs R D 10: 83–90. doi: 10.2165/11539320-000000000-00000 20698716
19. Yuan GY, Wang BJ, Wei CM, Zhang R, Guo RC, (2008) LC-MS determination of p-(1-dimethylaminoethylimino) aniline: a metabolite of tribendimidine in human plasma. Chromatographia 68: 139–142.
20. Yoshimi N, Sugie S, Iwata H, Niwa K, Mori H, et al. (1988) The Genotoxicity of a Variety of Aniline Derivatives in a DNA-Repair Test with Primary Cultured Rat Hepatocytes. Mut Res 206: 183–191.
21. Przybojewska B, (1999) Assessment of aniline derivatives-induced DNA damage in the liver cells of B6C3F1 mice using the alkaline single cell gel electrophoresis ('comet') assay. Cancer Letters 147: 1–4. 10660081